HomeHome
ProductsProducts
Building BlocksBuilding Blocks
Heterocyclic ScaffoldsHeterocyclic Scaffolds
PurinesPurines
PentoxifyllinePentoxifylline

Pentoxifylline

In Stock•Starting at $8 for 1 mg•Purity ≥ 99%

CAS No.	6493-05-6
MDL No.	N/A
MF	C₁₃H₁₈N₄O₃
MW	278.31
InChI Key	BYPFEZZEUUWMEJ-UHFFFAOYSA-N

CUSTOM SYNTHESIS

Pricing & Availability

Pack Size	Purity	Price	Availability
1 mg	99%	$8	In Stock
1 g	99%	$11	In Stock
5 g	99%	$29	In Stock
10 g	99%	$53	In Stock
15 g	99%	$75	In Stock

Product Information

Pentoxifylline is an oxopurine.

CAS No.	6493-05-6
Product Name	Pentoxifylline

Irritant

Signal Word:Warning

HCode:H302

PCode:P264-P270-P301+P317-P330-P501

Studies related to this compound and its mechanism of action

Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor alpha.

Hepatology (Baltimore, Md.) • Vol. 33, Issue 1 • 2001

PMID: 11124822 DOI: 10.1053/jhep.2001.20643

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.

Clinical immunology (Orlando, Fla.) • Vol. 98, Issue 2 • 2001

PMID: 11161985 DOI: 10.1006/clim.2000.4964

Progressive hearing loss in hearing impaired children: immediate results of antiphlogistic--rheologic infusion therapy.

International journal of pediatric otorhinolaryngology • Vol. 57, Issue 2 • 2001

PMID: 11165650 DOI: 10.1016/s0165-5876(00)00455-9

Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.

The British journal of dermatology • Vol. 144, Issue 1 • 2001

PMID: 11167702 DOI: 10.1046/j.1365-2133.2001.03970.x

Similar Products

Pentifylline
CAS No.1028-33-7
Lisofylline
CAS No.100324-81-0
(S)-Lisofylline
CAS No.100324-80-9
(+/-)-Lisofylline
CAS No.6493-06-7
Propentofylline
CAS No.55242-55-2

Products
- CDMO Compounds
- API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact

HomeHome
ProductsProducts
Building BlocksBuilding Blocks
Heterocyclic ScaffoldsHeterocyclic Scaffolds
PurinesPurines
PentoxifyllinePentoxifylline

Pentoxifylline

In Stock•Starting at $8 for 1 mg•Purity ≥ 99%

CAS No.	6493-05-6
MDL No.	N/A
MF	C₁₃H₁₈N₄O₃
MW	278.31
InChI Key	BYPFEZZEUUWMEJ-UHFFFAOYSA-N

CUSTOM SYNTHESIS

Pricing & Availability

Pack Size	Purity	Price	Availability
1 mg	99%	$8	In Stock
1 g	99%	$11	In Stock
5 g	99%	$29	In Stock
10 g	99%	$53	In Stock
15 g	99%	$75	In Stock

Product Information

Pentoxifylline is an oxopurine.

CAS No.	6493-05-6
Product Name	Pentoxifylline

Irritant

Signal Word:Warning

HCode:H302

PCode:P264-P270-P301+P317-P330-P501

Studies related to this compound and its mechanism of action

Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor alpha.

Hepatology (Baltimore, Md.) • Vol. 33, Issue 1 • 2001

PMID: 11124822 DOI: 10.1053/jhep.2001.20643

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.

Clinical immunology (Orlando, Fla.) • Vol. 98, Issue 2 • 2001

PMID: 11161985 DOI: 10.1006/clim.2000.4964

Progressive hearing loss in hearing impaired children: immediate results of antiphlogistic--rheologic infusion therapy.

International journal of pediatric otorhinolaryngology • Vol. 57, Issue 2 • 2001

PMID: 11165650 DOI: 10.1016/s0165-5876(00)00455-9

Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.

The British journal of dermatology • Vol. 144, Issue 1 • 2001

PMID: 11167702 DOI: 10.1046/j.1365-2133.2001.03970.x

Similar Products

Pentifylline
CAS No.1028-33-7
Lisofylline
CAS No.100324-81-0
(S)-Lisofylline
CAS No.100324-80-9
(+/-)-Lisofylline
CAS No.6493-06-7
Propentofylline
CAS No.55242-55-2

Your Partner for
Complex Chemistry

About Us
Perspectives
Products
Contact

Preclinical Development
Technologies
Custom Synthesis

Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT

Westerstraat 10, 3016 DH, Rotterdam, The Netherlands

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|

Pentoxifylline

Pricing & Availability

Product Information

Safety Information

Properties

Pentoxifylline

Pricing & Availability

Product Information

Safety Information

Properties

Documentation

Pentoxifylline

Pricing & Availability

Product Information

Safety Information

Properties

Related Articles

Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor alpha.

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.

Progressive hearing loss in hearing impaired children: immediate results of antiphlogistic--rheologic infusion therapy.

Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.

Similar Products

Pentifylline

Lisofylline

(S)-Lisofylline

(+/-)-Lisofylline

Propentofylline

Pentoxifylline

Pricing & Availability

Product Information

Safety Information

Properties

Related Articles

Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor alpha.

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.

Progressive hearing loss in hearing impaired children: immediate results of antiphlogistic--rheologic infusion therapy.

Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.

Similar Products

Pentifylline

Lisofylline

(S)-Lisofylline

(+/-)-Lisofylline

Propentofylline

Documentation